Canada’s Task Force Highlights Challenges and Recommendations for Post-COVID-19 Condition (PCC)
Summary
Consultative roundtables in 2022 emphasized the prevalence of Post-COVID-19 condition (PCC) in Canada, estimated to affect 10-20% of SARS-CoV-2 infected individuals. PCC lacks a unified definition, making diagnosis challenging, and the virus’s interaction with ACE2 is identified as a key aspect. The need for practical community support and flexible return-to-work arrangements for PCC individuals is emphasized, along with the importance of research into biological triggers and pathways. Recommendations include a comprehensive research strategy and a Pan-Canadian Health Data Strategy.
Main Points:
- Prevalence estimates for PCC in Canada range from 10-20% of individuals previously infected with SARS-CoV-2.
- PCC lacks a consensus definition or diagnosis, posing challenges in understanding and addressing the condition.
- Recommendations stress the necessity for practical community support, flexible return-to-work arrangements, and comprehensive research strategies to tackle PCC.
Sources:
- Task Force consultative roundtables
- Preprint “Physical, psychological and cognitive profile of post-COVID condition in health care workers, Quebec, Canada”
- Statistics Canada report on long-term symptoms in Canadian adults who tested positive for COVID-19
- Various articles and reports from reputable sources such as the World Economic Forum, Washington Post, and World Economic Forum.
Practical community supports and flexible return-to-work arrangements are needed for individuals living with PCC. Research on the biological triggers and pathways underlying PCC is essential for diagnostics and therapeutic avenues.
Science Advisor Canada
